Repare Therapeutics Inc (NASDAQ:RPTX)
| Market Cap | 414.05M |
|---|---|
| Revenue | 0 |
| Gross Profit | 0 |
| Shares Out | 42.08M |
| EPS (ttm) | |
| PE Ratio | 0.0000 |
| Forward PE | -3.5523 |
| Dividend Rate (ttm) | 0.0000 |
| Dividend Yield | 0.0000 |
| Trading Day | Mar 31 |
|---|---|
| Last Price | $9.84 |
| Previous Close | $9.45 |
| Change ($) | 0.39 |
| Change (%) | 4.13% |
| Day's Open | 9.49 |
| Day's Range | 9.48 - 10.08 |
| Day's Volume | 152.36K |
| 52 Week Range | 8.07 - 18.68 |
About Repare Therapeutics Inc
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair.
The Company's pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor currently in Phase 1/2 clinical development, as well as RP-6306, a CCNE1-SL inhibitor, and a Polθ inhibitor program.
News
Quick info
Repare Therapeutics Inc dividends
Total Valuation
Repare Therapeutics Inc has a market cap or net worth of $414.05 million. The enterprise value is $0.
Important Dates
Share Statistics
Repare Therapeutics Inc has 42.08 million shares outstanding.
Valuation Ratios
The trailing PE ratio is 0.0000 and the forward PE ratio is -3.5523. Repare Therapeutics Inc's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has decreased by -0.3311%. The beta is 1.3658, so Repare Therapeutics Inc's price volatility has been higher than the market average.
Income Statement
In the last 12 months, Repare Therapeutics Inc had revenue of $0 and earned $0 in profits. Earnings per share was $.